OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake
Harvey Checkoway, Karen M. Powers, Terri Smith‐Weller, et al.
American Journal of Epidemiology (2002) Vol. 155, Iss. 8, pp. 732-738
Open Access | Times Cited: 372

Showing 1-25 of 372 citing articles:

Epidemiology of Parkinson's disease
Lonneke ML de Lau, Monique M.B. Breteler
The Lancet Neurology (2006) Vol. 5, Iss. 6, pp. 525-535
Closed Access | Times Cited: 3881

Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
Tarique Hussain, Bie Tan, Yulong Yin, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 1697

The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Nour Yahfoufi, Nawal Alsadi, Majed Jambi, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 1338

Epidemiology and etiology of Parkinson’s disease: a review of the evidence
Karin Wirdefeldt, Hans‐Olov Adami, Philip Cole, et al.
European Journal of Epidemiology (2011) Vol. 26, Iss. S1, pp. 1-58
Open Access | Times Cited: 1148

Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action
David Vauzour, Ana Rodríguez-Mateos, Giulia Corona, et al.
Nutrients (2010) Vol. 2, Iss. 11, pp. 1106-1131
Open Access | Times Cited: 774

Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets
Charles Ramassamy
European Journal of Pharmacology (2006) Vol. 545, Iss. 1, pp. 51-64
Closed Access | Times Cited: 681

Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
Ana Rodríguez-Mateos, David Vauzour, Christian G. Krueger, et al.
Archives of Toxicology (2014) Vol. 88, Iss. 10, pp. 1803-1853
Closed Access | Times Cited: 549

The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain
Gary E. Swan, Christina N. Lessov‐Schlaggar
Neuropsychology Review (2007) Vol. 17, Iss. 3, pp. 259-273
Closed Access | Times Cited: 534

EPIDEMIOLOGY OFNEURODEGENERATION
Richard Mayeux
Annual Review of Neuroscience (2003) Vol. 26, Iss. 1, pp. 81-104
Closed Access | Times Cited: 518

The neuroprotective potential of flavonoids: a multiplicity of effects
David Vauzour, Katerina Vafeiadou, Ana Rodríguez-Mateos, et al.
Genes & Nutrition (2008) Vol. 3, Iss. 3-4, pp. 115-126
Open Access | Times Cited: 509

Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases
Orly Weinreb, Silvia Mandel, Tamar Amit, et al.
The Journal of Nutritional Biochemistry (2004) Vol. 15, Iss. 9, pp. 506-516
Open Access | Times Cited: 492

Neurodegenerative Diseases: An Overview of Environmental Risk Factors
Rebecca C. Brown, Alan H. Lockwood, Babasaheb Sonawane
Environmental Health Perspectives (2005) Vol. 113, Iss. 9, pp. 1250-1256
Open Access | Times Cited: 472

Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases
Silvia Mandel, Moussa B. H. Youdim
Free Radical Biology and Medicine (2004) Vol. 37, Iss. 3, pp. 304-317
Closed Access | Times Cited: 442

Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease
Robert J. Williams, Jeremy P. E. Spencer
Free Radical Biology and Medicine (2011) Vol. 52, Iss. 1, pp. 35-45
Closed Access | Times Cited: 425

Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
Shinichi Kuriyama, Atsushi Hozawa, Kaori Ohmori, et al.
American Journal of Clinical Nutrition (2006) Vol. 83, Iss. 2, pp. 355-361
Open Access | Times Cited: 412

Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases
Silvia Mandel, Orly Weinreb, Tamar Amit, et al.
Journal of Neurochemistry (2004) Vol. 88, Iss. 6, pp. 1555-1569
Closed Access | Times Cited: 357

The impact of fruit flavonoids on memory and cognition
Jeremy P. E. Spencer
British Journal Of Nutrition (2010) Vol. 104, Iss. S3, pp. S40-S47
Open Access | Times Cited: 350

Multifunctional Activities of Green Tea Catechins in Neuroprotection
Silvia Mandel, Yael Avramovich‐Tirosh, Lydia Reznichenko, et al.
Neurosignals (2005) Vol. 14, Iss. 1-2, pp. 46-60
Open Access | Times Cited: 342

Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Beate Ritz, Alberto Ascherio, Harvey Checkoway, et al.
Archives of Neurology (2007) Vol. 64, Iss. 7, pp. 990-990
Open Access | Times Cited: 334

Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
Finlay Dick, Giuseppe De Palma, Ahmad Ahmadi, et al.
Occupational and Environmental Medicine (2007) Vol. 64, Iss. 10, pp. 666-672
Open Access | Times Cited: 309

Natural and synthetic antioxidants: An updated overview
Agnieszka Augustyniak, Grzegorz Bartosz, Ana Čipak Gašparović, et al.
Free Radical Research (2010) Vol. 44, Iss. 10, pp. 1216-1262
Closed Access | Times Cited: 294

Genetics of caffeine consumption and responses to caffeine
Amy H. Yang, Abraham A. Palmer, Harriet de Wit
Psychopharmacology (2010) Vol. 211, Iss. 3, pp. 245-257
Open Access | Times Cited: 271

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Neha Atulkumar Singh, Abul Kalam Azad Mandal, Zaved Ahmed Khan
Nutrition Journal (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 261

Page 1 - Next Page

Scroll to top